Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐<i>versus</i>‐host disease — a real‐world outcomes analysisSameem Abedin, Mehdi Hamadani, Mark A. Schroeder et al.|British Journal of Haematology|2021Cited by 25